Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AML
AML
Here's Why GlycoMimetics Could Become a Takeover Target
Yahoo/Motley Fool
Sun, 12/17/17 - 11:36 am
GlycoMimetics
M&A
GMI-1271
AML
acute myeloid leukemia
Pfizer
FDA Approves Pfizer’s Mylotarg 7 Years After it was Pulled From the Market
RAPS.org
Fri, 09/1/17 - 04:06 pm
Pfizer
FDA
Mylotarg
acute myeloid leukemia
AML
FDA approves Jazz Pharmaceuticals’ liposomal AML chemotherapy
Drug Delivery Business News
Tue, 08/8/17 - 10:05 am
FDA
Jazz Pharmaceuticals
liposomal chemotherapy
Vyxeos
AML
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A next?
Fierce Pharma
Thu, 08/3/17 - 09:49 pm
Jazz Pharmaceuticals
FDA
AML
Vyxeos
M&A
FDA padlocks any new human tests on Seattle Genetics’ cancer drug in the wake of more deaths
Endpoints
Thu, 06/22/17 - 09:38 am
FDA
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Times, WA
Mon, 06/19/17 - 11:38 pm
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML
Endpoints
Sat, 04/29/17 - 10:02 am
Novartis
FDA
Rydapt
chemotherapy
AML
acute myeloid leukemia
Seattle Genetics to resume trials as FDA lifts clinical hold
Yahoo/Reuters
Mon, 03/6/17 - 09:52 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
AML
acute myeloid leukemia
Celgene, Agios beat a short path to an FDA decision on AML drug
Endpoints
Wed, 03/1/17 - 08:53 pm
Celgene
Agios
FDA
AML
enasidenib
acute myeloid leukemia
Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yahoo
Mon, 09/19/16 - 09:51 am
Seattle Genetics
clinical trials
SGN-CD123A
AML
acute myeloid leukemia
Celator Pharmaceuticals Nabs a Key FDA Designation, Readies for 2017
Motley Fool
Thu, 05/19/16 - 10:14 pm
Celator Pharmaceuticals
FDA
Vyxeos
AML
acute myeloid leukemia
Is This the End of Sunesis?
24/7 Wall St
Fri, 07/24/15 - 06:00 pm
Sunesis
FDA
AML
vosaroxin
acute myeloid leukemia
Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML)
Yahoo
Mon, 06/1/15 - 09:58 am
Asterias
AST-VAC1
AML
acute myelogenous leukemia
Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1
Yahoo
Tue, 04/21/15 - 09:25 am
Asterias
clinical trials
AST-VAC1
vaccines
AML
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
TheStreet.com
Wed, 11/19/14 - 08:30 am
Agios Pharmaceuticals
leukemia
AG-120
AML
Actinium: Cash In The Bank And Catalysts Ahead
Seeking Alpha
Tue, 02/4/14 - 08:07 am
Actinium Pharmaceuticals
AML
Actimab-A
Iomab-B HSCT
BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
Reuters
Thu, 01/23/14 - 07:51 am
stem cells
BioLineRx
BL-8040
AML
acute myeloid leukemia
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
BioLineRx Enrolls First Patient in Study
Yahoo/Zacks
Fri, 06/7/13 - 05:52 pm
BioLineRx
BL-8040
AML
acute myeloid leukemia
Cell Therapeutics announces positive results from OPAL study of tosedostat
Yahoo/Fly on the Wall
Mon, 03/4/13 - 10:57 am
tosedostat
Cell Therapeutics
Chroma Therapeutics
AML
acute myeloid leukemia
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »